United States
Germany
Japan
United Kingdom
China
CNY 6,881.00
6周
Antibodies
CNY 6,881.00
6周
Recombinant Anti-CD40L (Clone hu5c8 (Ruplizumab))
| Applications | Bl, FC, WB |
| Reactivities | Human |
Recombinant Anti-CD11a (Clone hu1124 (Efalizumab))
| Applications | Bl, FC |
| Reactivities | Human |
Recombinant Anti-VEGF (Clone Bevacizumab)
| Applications | Bl, ELISA, FC, IP, WB |
| Reactivities | Human |
Recombinant Anti-TNF alpha (Clone D2E7 (Adalimumab))
| Applications | Bl, ELISA, IF, IHC |
| Reactivities | Human |
Recombinant Anti-EGFR domain III (Clone h-R3 (Nimotuzumab))
| Applications | Bl, FC, IHC |
| Reactivities | Human |
Recombinant Anti-CD22 (Clone hL22 (Epratuzumab))
| Applications | Bl, FC, IP |
| Reactivities | Human, Monkey |
Recombinant Anti-CD41 (Clone 7E3 (Abciximab))
| Applications | Bl, FC |
| Reactivities | Human |
Recombinant Anti-PD-L1 (Clone 332M7)
| Applications | Bl, FC |
| Reactivities | Human, Mouse, Monkey |
Recombinant Anti-OX40L (Clone R4930 (Oxelumab))
| Applications | Bl, FC |
| Reactivities | Human |
